Cyclacel pharmaceuticals reports q2 loss per share of $0.58

Cyclacel pharmaceuticals reports second quarter 2020 financial results.cyclacel pharmaceuticals - estimates cash resources of $25.3 million as of june 30 will fund currently planned programs through 2022.cyclacel pharmaceuticals inc quarterly loss per share $0.58.

CYCC Ratings Summary

CYCC Quant Ranking